Market Overview:
The global cell therapy technologies market is expected to grow at a CAGR of 16.5% from 2018 to 2030. The growth in this market can be attributed to the increasing demand for cell therapies for various applications, such as human and animal applications. In addition, the increasing investments by key players in this market is also contributing to the growth of this market. On the basis of type, the global cell therapy technologies market can be segmented into equipment, consumables, and others. The equipment segment is expected to account for a major share of the global cell therapy technologies market in 2018. This segment is projected to grow at a CAGR of 16% from 2018 to 2030 owing to rising demand for advanced equipment for performing various types of cell therapies.
Product Definition:
Cell therapy technologies are used to improve the health of cells in the body. This can be done by using technology to remove toxins from the cells, or by providing nutrients that improve cell health. The importance of cell therapy technologies is that they can help improve overall health and wellness.
Equipment:
Equipment is the technology used to perform a specific function in cell therapy. It can be categorized on the basis of usage into instruments, devices and bioreactors. The growth factor for equipment market is expected to grow at a lucrative rate during forecast period owing to increasing investment by companies in this sector coupled with rising awareness regarding cell therapies among patients & healthcare professionals.
Consumables:
The global consumables and it's usage in cell therapy technologies market size was valued at USD 2.5 billion in 2016. The increasing demand for advanced therapies coupled with the rising prevalence of chronic diseases is expected to be a key factor driving growth over the forecast period.
Application Insights:
The human cell therapy segment dominated the global market in 2017. This can be attributed to an increase in cancer cases and a rise in demand for innovative therapies that are currently available only at advanced stages of clinical development. For instance, Glybera, a gene therapy product manufactured by Loxo Oncology is designed to treat patients with Non-Small Cell Lung Cancer (NSCLC). The company has raised approximately USD 120 million from investors such as Fidelity Management & Research Company and MassMutual Life Insurance Company for its late-stage pipeline products.
Animal cell therapy is anticipated to witness lucrative growth over the forecast period owing to rising use of companion animals for medical purposes such as physical support during chemotherapy sessions or radiation treatments. Moreover, growing use of stem cells derived from donors animal tissues or fluids have aided this segment¢â‚¬â„¢s growth further.
Regional Analysis:
North America dominated the global market in 2017. The presence of a large number of industry players, favorable government regulations and initiatives, and high healthcare expenditure are some factors contributing to its growth. In addition, increasing research activities for developing novel therapies is expected to drive the regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising disposable income levels in emerging economies such as China and India. Moreover, an increase in chronic disease burden coupled with growing investments by governments for improving healthcare infrastructure is likely to boost demand for cell therapy products over the coming years.
Growth Factors:
- Increasing demand for cell therapies to treat various diseases and disorders
- Growing number of clinical trials for cell therapies
- Rising public and private investments in cell therapy research and development
- Advances in technology that improve the efficiency and effectiveness of cell therapies
- Increasing number of partnerships between pharmaceutical companies, biotechnology firms, and academic institutions to develop new cell therapies
Scope Of The Report
Report Attributes
Report Details
Report Title
Cell Therapy Technologies Market Research Report
By Type
Equipment, Consumables, Others
By Application
Human, Animal
By Companies
Danaher, Thermo Fisher Scientific, Merck, Terumo, BD, Lonza Group, GE Healthcare, Sartorius, Stemcell Technologies, Miltenyi Biotec
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
243
Number of Tables & Figures
171
Customization Available
Yes, the report can be customized as per your need.
Global Cell Therapy Technologies Market Report Segments:
The global Cell Therapy Technologies market is segmented on the basis of:
Types
Equipment, Consumables, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Human, Animal
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Danaher
- Thermo Fisher Scientific
- Merck
- Terumo
- BD
- Lonza Group
- GE Healthcare
- Sartorius
- Stemcell Technologies
- Miltenyi Biotec
Highlights of The Cell Therapy Technologies Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Equipment
- Consumables
- Others
- By Application:
- Human
- Animal
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cell Therapy Technologies Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cell therapy technologies are used to treat diseases by transplanting healthy cells into the body.
Some of the major companies in the cell therapy technologies market are Danaher, Thermo Fisher Scientific, Merck, Terumo, BD, Lonza Group, GE Healthcare, Sartorius, Stemcell Technologies, Miltenyi Biotec.
The cell therapy technologies market is expected to grow at a compound annual growth rate of 16.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cell Therapy Technologies Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cell Therapy Technologies Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cell Therapy Technologies Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cell Therapy Technologies Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cell Therapy Technologies Market Size & Forecast, 2020-2028
4.5.1 Cell Therapy Technologies Market Size and Y-o-Y Growth
4.5.2 Cell Therapy Technologies Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Equipment
5.2.2 Consumables
5.2.3 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Human
6.2.2 Animal
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cell Therapy Technologies Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cell Therapy Technologies Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Equipment
9.6.2 Consumables
9.6.3 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Human
9.10.2 Animal
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Equipment
10.6.2 Consumables
10.6.3 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Human
10.10.2 Animal
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Equipment
11.6.2 Consumables
11.6.3 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Human
11.10.2 Animal
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Equipment
12.6.2 Consumables
12.6.3 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Human
12.10.2 Animal
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Equipment
13.6.2 Consumables
13.6.3 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Human
13.10.2 Animal
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cell Therapy Technologies Market: Competitive Dashboard
14.2 Global Cell Therapy Technologies Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Danaher
14.3.2 Thermo Fisher Scientific
14.3.3 Merck
14.3.4 Terumo
14.3.5 BD
14.3.6 Lonza Group
14.3.7 GE Healthcare
14.3.8 Sartorius
14.3.9 Stemcell Technologies
14.3.10 Miltenyi Biotec
